Wayfinding Financial’s Labcorp LH Stock Holding History

Wayfinding Financial’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-340	Closed	-$79K	–	474
2025 Q1	$79K	Buy	+340	New	+$82.5K	0.03%	266

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wayfinding Financial's LH Position: Q2 2025 in Review

Wayfinding Financial sold out of Labcorp (LH) in Q2 2025, closing a stake of 340 shares — an estimated $79K sold.

Wayfinding Financial first reported a position in LH in Q1 2025 and held it in 1 quarter. The position peaked at $79K in Q1 2025. 973 funds tracked by Wall St. Rank hold LH as of Q2 2025.

Wayfinding Financial reported no remaining Labcorp position as of Q2 2025 after selling out during the quarter.
Wayfinding Financial sold 340 Labcorp shares in Q2 2025, an estimated $79K.
Wayfinding Financial first reported a position in Labcorp in Q1 2025 and held it in 1 quarter.
Wayfinding Financial's Labcorp position peaked at $79K in Q1 2025.
973 funds tracked by Wall St. Rank held Labcorp as of Q2 2025.

Based on Wayfinding Financial's 13F filing for Q2 2025, filed 12 Aug 2025.